1. Home
  2. ZLAB vs AAP Comparison

ZLAB vs AAP Comparison

Compare ZLAB & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • AAP
  • Stock Information
  • Founded
  • ZLAB 2013
  • AAP 1929
  • Country
  • ZLAB China
  • AAP United States
  • Employees
  • ZLAB N/A
  • AAP N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • AAP Auto & Home Supply Stores
  • Sector
  • ZLAB Health Care
  • AAP Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • AAP Nasdaq
  • Market Cap
  • ZLAB 3.2B
  • AAP 3.3B
  • IPO Year
  • ZLAB 2017
  • AAP N/A
  • Fundamental
  • Price
  • ZLAB $20.98
  • AAP $49.09
  • Analyst Decision
  • ZLAB Buy
  • AAP Hold
  • Analyst Count
  • ZLAB 6
  • AAP 20
  • Target Price
  • ZLAB $57.22
  • AAP $52.28
  • AVG Volume (30 Days)
  • ZLAB 899.6K
  • AAP 1.8M
  • Earning Date
  • ZLAB 11-06-2025
  • AAP 10-30-2025
  • Dividend Yield
  • ZLAB N/A
  • AAP 2.04%
  • EPS Growth
  • ZLAB N/A
  • AAP N/A
  • EPS
  • ZLAB N/A
  • AAP N/A
  • Revenue
  • ZLAB $441,629,000.00
  • AAP $8,624,327,000.00
  • Revenue This Year
  • ZLAB $40.71
  • AAP N/A
  • Revenue Next Year
  • ZLAB $50.42
  • AAP $0.89
  • P/E Ratio
  • ZLAB N/A
  • AAP N/A
  • Revenue Growth
  • ZLAB 24.14
  • AAP N/A
  • 52 Week Low
  • ZLAB $20.61
  • AAP $28.89
  • 52 Week High
  • ZLAB $44.34
  • AAP $70.00
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 21.54
  • AAP 42.33
  • Support Level
  • ZLAB $21.59
  • AAP $46.11
  • Resistance Level
  • ZLAB $22.28
  • AAP $52.17
  • Average True Range (ATR)
  • ZLAB 0.86
  • AAP 3.12
  • MACD
  • ZLAB -0.18
  • AAP 0.23
  • Stochastic Oscillator
  • ZLAB 6.41
  • AAP 24.48

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About AAP Advance Auto Parts Inc.

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.

Share on Social Networks: